CD40 and Autoimmunity: Novel miRNA dysregulated in autoimmunity are continuously being discovered [199,200,201], many of which control key pathways in B cell activation, including CD40–CD40L interaction [202,203], TLR and type I interferon signaling [204], the GC response, and AID expression [205,206,207,208].